放射性核素显像在轻度认知功能障碍中的应用价值

袁瑛; 顾兆祥

袁瑛 , 顾兆祥

文章导航 > 国际放射医学核医学杂志 > 2008, 32 > 4: (209-213)

引用本文:

Citation:

放射性核素显像在轻度认知功能障碍中的应用价值

袁瑛,
顾兆祥^,

200040 上海, 复旦大学附属华东医院核医学科

通讯作者: 顾兆祥, guzx2222@yahoo.com.cn

Applications of radionuclide imaging in mild cognitive impairment

YUAN Ying,
GU Zhao-xiang^,

Department of Nuclear Medwine, Huadong Hospital, Fudan University, Shanghai 200040, China

Corresponding author: GU Zhao-xiang, guzx2222@yahoo.com.cn

摘要: 轻度认知功能障碍(MCI)患者存在进展为痴呆的高度危险,早期发现将进展为阿尔茨海默病(AD)的MCI有重要的实验研究和临床意义。放射性核素显像已广泛应用于研究MCI脑代谢和脑血流量以及评价MCI的预后。综述了近年来放射性核素显像以及与载脂蛋白E基因型分析等其他方法联合使用对于MCI预后判断的价值。
- 认知障碍 /
- 阿尔茨海默病 /
- 基因,载脂蛋白E /
- 放射性核素显像
Abstract: The risk for conversion to dementia is much higher in individuals with mild eoghitived impairmaent (MCI).The early detection of MCI individuals who will later convert to Alzheimer disease is an important issue for both clinical and research interests.Radionuclide imaging has been broadly used to study cerebral membolism and blood flow,as well as predicting the prognosis of MCI.This review summarizes the results of these studies assessing the predicting value of radionuelide imaging used alone and with other methods in recent years.
- Cognition disorders /
- Ahheimer disease /
- Gene,apolipoprotein E /
- Radionuelide imaging
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Petersen RC.Mild cognitive impairment as a diagnostic entity[J].J Intern Med,2004,256(3):183-194.
[2]	Petersen RC,Doody R,Kurz A,et al.Current concepts in mild cognitive imparment[J].Arch Neurol,2001,58(12):1985-1992.
[3]	Johnson KA,Moran EK Becker JA.et al.Single photon emission computed tomography perfusion differences in mild cognitive impairment[J].J Neural Neurosurg Psychiatry,2007,78(3):240-247.
[4]	Hirao K Ohnishi T, Hirata Y,et al.The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT[J].Neuroimage,2005, 28(4):1014-1021.
[5]	Ishiwata A,Sakayori O,Mineshima S.et al.Preclinical evidence of Alzheimer changes in progressive mild cognitive impairment:a qualitative and quantitative SPECT study[J].Acta Neurol Scand,2006,114(2):91-96.
[6]	高平,秦绍森,蔡晓杰,等.Alzheimer病与轻度认知功能障碍的脑SPECT显像[J].中华核医学杂志,2006,26(4):213-215.
[7]	Chételat G,Desgranges B,de la Sayette V,et al.Mild cognitive impairment:Can FDG-PET predict who is to rapidly convert to Alzheimer's disease?[J].Neurology,2003,60(8):1374-1377.
[8]	Pardo JV,Lee JT,Sheikh SA.et al.Where the brain grows old: decline in anterior cingulate and medial prefrontal function with normal agindfl.Neuroimage,2007,35(3):1231-1237.
[9]	Mosconi L,De Santi S,Li J,et al.Hippocampal hypometabotism predicts cognitive decline from normal aging[J].Neurobiol Aging, 2008,29(5):676-692.
[10]	Kropholler MA,Boellaard R,van Berckel BN,et al.Evaluation of reference regions for (R)-[(11)C] PKlll95 studies in Alzheimer's disease and mild cognitive impairment[J].J Cereb Blood Flow Metab,2007,27(12):1965-1974.
[11]	Hasselbalch SG,Madsen K,Svarer C.et al.Reduced 5-HT2A.receptor binding in patients with mild cognitive impairment[J]. Neurobiol Aging,2008,29(12):1830-1838.
[12]	Huang C,Eidelberg D,Habeck C,et al.Imaging markers of mild cognitive impairment:multivariate analysis of CBF SPECT[J]. Neurobiol Aging,2007,28(7):1062-1069.
[13]	Borroni B,Anchisi D,Paghera B.et al.Combined ⁹⁰Tc-ECD SPECT and neurepsychological studies in MCI fur the assessment of conversion to AD[J].Neurobiol Aging,2006,27(1):24-31.
[14]	王荫华,陈晓红,汤哲,等.轻度认知功能障碍的神经心理学研究和ApoE基因多态性分析[J].中国康复理论与实践,2005,11(3):202-205.
[15]	Mosconi L Herholz k Prohovnik I,et al.Metabolic interaction between ApoE genotype and onset age in Alzheimer's disease: implications for brain reserve[J].J Neurol Neurosurg Psychiatry. 2005,76(1):15-23.
[16]	Drzezga A,Grimmer T,Riemenschneider M,et al.Prediction of individual clinical outcome in MCI by means of genetic assessment and ¹⁸F-FDG PET[J].J Nucl Med,2005,46(10):1625-1632.
[17]	Mosconi L.Perani,D,Sorbi S,et al.MCl conversion to dementia and the APOE genotype:a prediction study with FDG-PET[J].Neurology,2004,63(12):2332-2340.
[18]	Forsberg A,Engler H,Almkvist O,et al.PET imaging of amyloid deposition in pafients with mild cognitive impairment[J].Neurobiol Aging,2008.29(10):1456-1465.
[19]	Fellgiebel A,Scheufieh A,Bartenstein P,et al.FDG-PET and CSF phospho-tau for prediction of cognitive decline in mild cognitive impairment[J].Psychiatry Res,2007,155(2):167-171.

[1]	李祖贵 . 轻度认知障碍的功能性神经影像学研究进展. 国际放射医学核医学杂志, 2006, 30(2): 76-79.
[2]	郭喆 , 张锦明 . 阿尔茨海默病的放射性分子显像探针研究进展. 国际放射医学核医学杂志, 2006, 30(4): 199-202.
[3]	暴丽洁 , 赵子龙 , 苏宁 , 周茂荣 . MRI和PET显像在阿尔茨海默病早期诊断中的应用. 国际放射医学核医学杂志, 2023, 47(4): 249-253. doi: 10.3760/cma.j.cn121381-202211009-00288
[4]	贾路路 , 郭昆冈 , 唐红军 , 付巍 . 阿尔茨海默病相关正电子显像剂的研究进展. 国际放射医学核医学杂志, 2023, 47(3): 190-195. doi: 10.3760/cma.j.cn121381-202209012-00279
[5]	武晓丹 , 战莹 , 郭佳 , 陈宇峰 , 郝珊瑚 , 张国旭 , 王治国 . 脑脊液生物标志物与¹¹C-PIB PET/CT显像对阿尔茨海默病的诊断准确率及相关性研究. 国际放射医学核医学杂志, 2021, 45(1): 3-9. doi: 10.3760/cma.j.cn121381-202004019-00003
[6]	王瑞民 . 阿尔茨海默病等痴呆疾病的脑功能影像学研究. 国际放射医学核医学杂志, 2001, 25(5): 209-212.
[7]	蔡汉成 , 尹端沚 , 张岚 , 李谷才 , 郑明强 , 汪勇先 . 早期诊断阿尔茨海默病的PET分子探针. 国际放射医学核医学杂志, 2006, 30(4): 202-205.
[8]	宗佳滨 , 兰晓莉 , 张永学 . 阿尔茨海默病分子影像探针的研究进展. 国际放射医学核医学杂志, 2022, 46(1): 35-41. doi: 10.3760/cma.j.cn121381-202101045-00129
[9]	王新艳 , 管一晖 . 阿尔茨海默病的影像学诊断进展. 国际放射医学核医学杂志, 2013, 37(1): 52-59. doi: 10.3760/cma.j.issn.1673-4114.2013.01.014
[10]	段小艺 , 李淼 , 王黎 , 李宏利 , 赵周社 , 郭佑民 . 阿尔茨海默病PET正电子药物应用与研究进展. 国际放射医学核医学杂志, 2014, 38(5): 318-322. doi: 10.3760/cma.j.issn.1673-4114.2014.05.010

点击查看大图

计量

文章访问数: 1462
HTML全文浏览量: 130
PDF下载量: 2

放射性核素显像在轻度认知功能障碍中的应用价值

袁瑛
顾兆祥^,

通讯作者: 顾兆祥, guzx2222@yahoo.com.cn

200040 上海, 复旦大学附属华东医院核医学科

收稿日期: 2007-11-22

关键词:

摘要: 轻度认知功能障碍(MCI)患者存在进展为痴呆的高度危险,早期发现将进展为阿尔茨海默病(AD)的MCI有重要的实验研究和临床意义。放射性核素显像已广泛应用于研究MCI脑代谢和脑血流量以及评价MCI的预后。综述了近年来放射性核素显像以及与载脂蛋白E基因型分析等其他方法联合使用对于MCI预后判断的价值。